Richard L. Lindstrom's Insider Trades & SAST Disclosures
Richard L. Lindstrom's most recent trade in Ocular Therapeutix Inc was a trade of 10,000 Common Stock done at an average price of $7.0 . Disclosure was reported to the exchange on May 8, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Richard L. Lindstrom.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ocular Therapeutix Inc | Richard L. Lindstrom | Director | Purchase of securities on an exchange or from another person at price $ 6.96 per share. | 08 May 2025 | 10,000 | 172,704 (0%) | 0% | 7.0 | 69,600 | Common Stock |
| LENSAR Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 22,000 | 239,036 | - | 0 | Common Stock | |
| Ocular Therapeutix Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Richard L. Lindstrom | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 18,939 | 0 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Richard L. Lindstrom | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.80 per share. | 27 Feb 2024 | 18,939 | 139,341 (0%) | 0% | 8.8 | 166,663 | Common Stock |
| Ocular Therapeutix Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 12,000 | 162,704 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Richard L. Lindstrom | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.80 per share. | 27 Feb 2024 | 11,363 | 150,704 (0%) | 0% | 8.8 | 99,994 | Common Stock |
| Ocular Therapeutix Inc | Richard L. Lindstrom | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 11,363 | 0 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,000 | 120,402 (0%) | 0% | 0 | Common Stock | |
| LENSAR Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 33,175 | 33,175 | - | - | Stock Option (Right to Buy) | |
| LENSAR Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 9,288 | 217,036 | - | 0 | Common Stock | |
| Harrow Health Inc | Richard L. Lindstrom | Director | Sale of securities on an exchange or to another person at price $ 12.62 per share. | 30 Sep 2022 | 40,000 | 26,100 (0%) | 0% | 12.6 | 504,800 | Common Stock |
| Ocular Therapeutix Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 26,800 | 26,800 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,933 | 108,402 (0%) | 0% | 0 | Common Stock | |
| Harrow Health Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 13,123 | 13,123 | - | - | RSU | |
| Ocular Therapeutix Inc | Richard L. Lindstrom | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2022 | 9,469 | 0 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Richard L. Lindstrom | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.22 per share. | 12 May 2022 | 9,469 | 99,469 (0%) | 0% | 1.2 | 11,552 | Common Stock |
| Harrow Health Inc | Richard L. Lindstrom | Director | Sale of securities on an exchange or to another person at price $ 10.04 per share. | 24 Sep 2021 | 3,900 | 66,100 (0%) | 0% | 10.0 | 39,156 | Common Stock |
| Harrow Health Inc | Richard L. Lindstrom | Director | Sale of securities on an exchange or to another person at price $ 9.09 per share. | 15 Sep 2021 | 14,160 | 75,840 (0%) | 0% | 9.1 | 128,714 | Common Stock |
| Harrow Health Inc | Richard L. Lindstrom | Director | Sale of securities on an exchange or to another person at price $ 9.02 per share. | 15 Sep 2021 | 5,840 | 70,000 (0%) | 0% | 9.0 | 52,677 | Common Stock |
| Harrow Health Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 9,644 | 9,644 | - | - | RSU | |
| Ocular Therapeutix Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Harrow Health Inc | Richard L. Lindstrom | Director | Sale of securities on an exchange or to another person at price $ 10.75 per share. | 20 May 2021 | 10,000 | 90,000 (0%) | 0% | 10.8 | 107,500 | Common Stock |
| LENSAR Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 20,847 | 20,847 | - | - | Stock Option (Right to Buy) | |
| LENSAR Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2020 | 32,127 | 203,463 | - | 0 | Common Stock | |
| Ocular Therapeutix Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Harrow Health Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 17,006 | 17,006 | - | - | RSU |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges